Related Experiment Videos
Immune considerations in tissue engineering
1Division of Plastic and Reconstructive Surgery, University of Pittsburgh School of Medicine, Pennsylvania, USA.
Clinics in Plastic Surgery
|November 30, 1999
Summary
This study explores strategies for controlling inflammation and immune rejection in tissue-engineered constructs. It focuses on modulating host responses to nonautologous cells and engineered tissues for better integration.
Area of Science:
- Biomaterials Science
- Immunology
- Regenerative Medicine
Background:
- Tissue engineering aims to create functional living tissues using natural and synthetic components.
- Host immune responses, including inflammation and rejection, pose significant challenges to the success of tissue-engineered constructs.
Purpose of the Study:
- To outline strategies for controlling early inflammatory and immune events in tissue-engineered constructs.
- To investigate methods for modulating host responses against nonautologous cells within constructs.
- To review the fate of genetically engineered cells used in ex vivo applications.
Main Methods:
- Multidisciplinary approach integrating immunology and biomaterials science.
- Strategies to control inflammatory biochemical events, cell migration, and matrix deposition.
- Modulatory techniques to arrest cell- and humoral-mediated rejection of nonautologous cells.
Main Results:
- Identification of key targets within tissue-engineered constructs for immune modulation.
- Development of strategies to mitigate inflammatory responses directed at the acellular component.
- Assessment of the host's reaction to ex vivo genetically engineered cells.
Conclusions:
- Controlling early inflammatory and immune responses is crucial for the success of tissue-engineered constructs.
- Targeting both cellular and humoral-mediated reactions can arrest rejection of nonautologous cells.
- Understanding the fate of genetically engineered cells is vital for optimizing therapeutic applications.